The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · see citing works

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma

Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492 · see citing works

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Dalmau, J. O., Lancaster, E., Martínez‐Hernández, E., Rosenfeld, M. R., & Balice‐Gordon, R. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,428 · see citing works

De novo mutations in schizophrenia implicate synaptic networks

Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617 · see citing works

Kynurenines in the mammalian brain: when physiology meets pathology

Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530 · see citing works

Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population

Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K. I., Isometsä, E. T., Pirkola, S. P., Partonen, T., Tuulio‐Henriksson, A., Hintikka, J., Kieseppä, T., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.19 · Cited by 1,523 · see citing works

A polygenic burden of rare disruptive mutations in schizophrenia

Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385 · see citing works

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database

Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P. A., Kavvoura, F. K., Khoury, M. J., Tanzi, R. E., & Bertram, L. (2008) · Nature Genetics · doi:10.1038/ng.171 · Cited by 1,054 · see citing works

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia

Kirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.154 · Cited by 844 · see citing works

D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release

Schell, M. J., Molliver, M. E., & Snyder, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3948 · Cited by 832 · see citing works

Serine racemase: A glial enzyme synthesizing <scp>d</scp> -serine to regulate glutamate- <i>N</i> -methyl- <scp>d</scp> -aspartate neurotransmission

Wolosker, H., Blackshaw, S., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13409 · Cited by 811 · see citing works

The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

Hilmas, C., Pereira, E., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 772 · see citing works

Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists

Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L., Pollegioni, L., Mothet, J., & Oliet, S. H. R. (2012) · Cell · doi:10.1016/j.cell.2012.06.029 · Cited by 752 · see citing works

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

Belforte, J. E., Zsiros, V., Sklar, E. R., Jiang, Z., Yu, G., Li, Y., Quinlan, E. M., & Nakazawa, K. (2010) · Nature Neuroscience · doi:10.1038/nn.2447 · Cited by 752 · see citing works

Effects of Ketamine in Normal and Schizophrenic Volunteers

Lahti, A. C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674 · see citing works

A Glycine Site Associated with N‐Methyl‐d‐Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists

Kessler, M., Terramani, T., Lynch, G., & Baudry, M. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb01881.x · Cited by 649 · see citing works

Increased cortical kynurenate content in schizophrenia

Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590 · see citing works

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.

Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 478 · see citing works

Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine

Mothet, J., Pollegioni, L., Ouanounou, G., Martineau, M., Fossier, P., & Baux, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408483102 · Cited by 461 · see citing works

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · see citing works

Modulation of N -methyl- d -aspartate receptor function by glycine transport

Bergeron, R., Meyer, T. M., Coyle, J. T., & Greene, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15730 · Cited by 412 · see citing works

Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia

Steiner, J. H., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.86 · Cited by 379 · see citing works

Endogenous d ‐Serine in Rat Brain: N‐Methyl‐ d ‐Aspartate Receptor‐Related Distribution and Aging

Hashimoto, A., Nishikawa, T., Oka, T., & Takahashi, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03219.x · Cited by 363 · see citing works

On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress

Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346 · see citing works

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior

Basu, A. C., Tsai, G. E., Ma, C.-L., Ehmsen, J. T., Mustafa, A. K., Han, L., Jiang, Z. I., Benneyworth, M. A., Froimowitz, M., LANGE, N. D., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.130 · Cited by 340 · see citing works

A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia

Bendikov, I., Nadri, C., Amar, S., Panizzutti, R., DEMIRANDA, J., Wolosker, H., & Agam, G. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.10.010 · Cited by 323 · see citing works

Localization of the GLYT1 Glycine Transporter at Glutamatergic Synapses in the Rat Brain

Cubelos, B. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh147 · Cited by 291 · see citing works

Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis

Tsai, G. E., & Lin, P. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361452 · Cited by 269 · see citing works

The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator ofN-Methyl-d-Aspartate Receptors

Paul, S. M., Doherty, J., Robichaud, A. J., Belfort, G. M., Chow, B. Y., Hammond, R., Crawford, D. C., Linsenbardt, A. J., Shu, H., Izumi, Y., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2619-13.2013 · Cited by 267 · see citing works

Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients

Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindström, L. H., & Iyo, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.023 · Cited by 267 · see citing works

Regional Distribution and Developmental Variation of the Glycine Transporters GLYT1 and GLYT2 in the Rat CNS

Zafra, F., Gomeza, J., Olivares, L., et al. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01125.x · Cited by 259 · see citing works

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

GOFF, D. C., Tsai, G. E., Manoach, D. S., & Coyle, J. T. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1213 · Cited by 243 · see citing works

Serine racemase is predominantly localized in neurons in mouse brain

Miya, K., Inoue, R., Takata, Y., Abe, M., Natsume, R., Sakimura, K., Hongou, K., Miyawaki, T., & Mori, H. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21822 · Cited by 243 · see citing works

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia

Weickert, C. S., Fung, S. J., Catts, V. S., Schofield, P. R., Allen, K. M., Moore, L., Newell, K. A., Pellen, D., Huang, X.-F., Catts, S. V., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.137 · Cited by 234 · see citing works

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

Coyle, J. T., & Tsai, G. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1709-2 · Cited by 230 · see citing works

Add-on Treatment of Benzoate for Schizophrenia

Lane, H., Lin, C., Green, M. F., Hellemann, G., Huang, C., Chen, P., Tun, R., Chang, Y.-C., & Tsai, G. E. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2159 · Cited by 229 · see citing works

Neuronal d-Serine and Glycine Release Via the Asc-1 Transporter Regulates NMDA Receptor-Dependent Synaptic Activity

Rosenberg, D., Artoul, S., Segal, A. C., Kolodney, G., Radzishevsky, I. S., Dikopoltsev, E., Foltyn, V. N., Inoue, R., Mori, H., Billard, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3836-12.2013 · Cited by 228 · see citing works

Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia

Jones, C. K., Byun, N. E., & Bubser, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 228 · see citing works

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction

Balu, D. T., Li, Y., Puhl, M. D., Benneyworth, M. A., Basu, A. C., Takagi, S., Bolshakov, V. Y., & Coyle, J. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304308110 · Cited by 217 · see citing works

Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention

Quartermain, D., Mower, J., Rafferty, M. F., Herting, R. L., & Lanthorn, T. H. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90687-4 · Cited by 190 · see citing works

Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex

Fossat, P., Turpin, F. R., Sacchi, S., Dulong, J., Shi, T., Rivet, J., Sweedler, J. V., Pollegioni, L., Millan, M. J., Oliet, S. H. R., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr130 · Cited by 185 · see citing works

Reduction of Brain Kynurenic Acid Improves Cognitive Function

Kozak, R., Campbell, B. M., Strick, C. A., Horner, W., Hoffmann, W. E., Kiss, T., Chapin, D. S., McGinnis, D. J., Abbott, A. L., Roberts, B. M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1107-14.2014 · Cited by 182 · see citing works

Storage and Uptake of d-Serine into Astrocytic Synaptic-Like Vesicles Specify Gliotransmission

Martineau, M., Shi, T., Puyal, J., Knolhoff, A. M., Dulong, J., Gasnier, B., Klingauf, J., Sweedler, J. V., Jahn, R., & Mothet, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3497-12.2013 · Cited by 172 · see citing works

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia

Verrall, L., Burnet, P. W. J., Betts, J. F., & Harrison, P. J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.99 · Cited by 171 · see citing works

Cell Selective Conditional Null Mutations of Serine Racemase Demonstrate a Predominate Localization in Cortical Glutamatergic Neurons

Benneyworth, M. A., Li, Y., Basu, A. C., Bolshakov, V. Y., & Coyle, J. T. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9808-4 · Cited by 153 · see citing works

Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: Facts and challenges

Albuquerque, E. X., & Schwarcz, R. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.014 · Cited by 150 · see citing works

Glycine transporters: essential regulators of synaptic transmission

Betz, H., Gomeza, J., Armsen, W., Scholze, P., & Eulenburg, V. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340055 · Cited by 148 · see citing works

Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult Brain

Yang, J. H., Wada, A., Yoshida, K., Miyoshi, Y., Sayano, T., Esaki, K., Kinoshita, M. O., Tomonaga, S., Azuma, N., Watanabe, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187443 · Cited by 147 · see citing works

d-Serine and Serine Racemase are Localized to Neurons in the Adult Mouse and Human Forebrain

Balu, D. T., Takagi, S., Puhl, M. D., Benneyworth, M. A., & Coyle, J. T. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0027-z · Cited by 126 · see citing works

Reduced Dysbindin Expression Mediates N-Methyl-D-Aspartate Receptor Hypofunction and Impaired Working Memory Performance

Karlsgodt, K. H., Robleto, K., Trantham‐Davidson, H., Jairl, C., Cannon, T. D., Lavı́n, A., & Jentsch, J. D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.012 · Cited by 119 · see citing works

D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase

Ehmsen, J. T., Ma, T. M., Sason, H., Rosenberg, D., Ogo, T., Furuya, S., Snyder, S. H., & Wolosker, H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4914-12.2013 · Cited by 118 · see citing works

Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology

DeVito, L. M., Balu, D. T., Kanter, B. R., Lykken, C., Basu, A. C., COYLE, J. T., & Eichenbaum, H. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00656.x · Cited by 114 · see citing works

A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia

Morita, Y., Ujike, H., Tanaka, Y., Otani, K., Kishimoto, M., Morio, A., Kotaka, T., Okahisa, Y., Matsushita, M., Morikawa, A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.025 · Cited by 112 · see citing works

Understanding structural brain changes in schizophrenia

DeLisi, L. E., Szulc, K. U., Bertisch, H. C., Majcher, M., & Brown, K. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.1/ldelisi · Cited by 106 · see citing works

Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia

Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109625108 · Cited by 103 · see citing works

Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level

Li, Y., Sacchi, S., Pollegioni, L., Basu, A. C., Coyle, J. T., & Bolshakov, V. Y. (2013) · Nature Communications · doi:10.1038/ncomms2779 · Cited by 82 · see citing works

CLC-3 Channels Modulate Excitatory Synaptic Transmission in Hippocampal Neurons

Wang, X. Q., Deriy, L. V., Foss, S., Huang, P., Lamb, F. S., Kaetzel, M. A., Bindokas, V. P., Marks, J. D., & Nelson, D. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.035 · Cited by 79 · see citing works

CASK Regulates SAP97 Conformation and Its Interactions with AMPA and NMDA Receptors

Lin, E. I., Jeyifous, O., & Green, W. N. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0816-13.2013 · Cited by 58 · see citing works

Genetic loss of D‐amino acid oxidase activity reverses schizophrenia‐like phenotypes in mice

Labrie, V., Wang, W., Barger, S. W., Baker, G. B., & Roder, J. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00529.x · Cited by 55 · see citing works

Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia

Goltsov, A. Y., Loseva, J. G., Андреева, Т. В., Grigorenko, A. P., Abramova, L. I., Каледа, В. Г., Александровна, О. В., Moliaka, Y. K., & Rogaev, E. I. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001801 · Cited by 50 · see citing works

Involvement of ClC-3 chloride/proton exchangers in controlling glutamatergic synaptic strength in cultured hippocampal neurons

Guzman, R. E., Alekov, A. K., Filippov, M., Hegermann, J., & Fahlke, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00143 · Cited by 38 · see citing works

Metabotropic Glutamate Receptors for New Treatments in Schizophrenia

Herman, E. J., Bubser, M., Conn, P. J., & Jones, C. K. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_11 · Cited by 35 · see citing works

Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686 · see citing works

Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis

Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works

Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms

Kantrowitz, J. T., Epstein, M. L., Lee, M., Lehrfeld, N., Nolan, K. A., Shope, C., Petkova, E., Silipo, G., & Javitt, D. C. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.02.027 · Cited by 123 · see citing works

Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses

Ferreira, J. S., Papouin, T., Ladépêche, L., Yao, A., Langlais, V. C., Bouchet, D., Dulong, J., Mothet, J.-P., Sacchi, S., Pollegioni, L., et al. (2017) · eLife · doi:10.7554/elife.25492 · Cited by 110 · see citing works

Maternal overnutrition induces long-term cognitive deficits across several generations

Sarker, G., & Peleg-Raibstein, D. (2018) · Nutrients · doi:10.3390/nu11010007 · Cited by 52 · see citing works

Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice

Hunt, M. J., Olszewski, M., Piasecka, J., Whittington, M. A., & Kasicki, S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4073-0 · Cited by 20 · see citing works

Dissecting the Pathophysiological Circuit Substrates of Reward and Anhedonia Subdomains

Trébaul, L., Ho, V. M., Ellard, K. K., Barbour, T. A., & Camprodon, J. A. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.711

Measuring behavior in mice with chronic stress depression paradigm

Strekalova, T., & Steinbusch, H. W. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.014 · Cited by 207 · see citing works

Relations Between Subcortical Volumes, Anhedonia Severity, and Reward-Oriented Behaviors in an Anhedonic Transdiagnostic Sample

Gibson, K., Cernasov, P., Walsh, E. C., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.692

Anhedonia in acute schizophrenia.

Sarkar, S., Praharaj, S. K., Chaudhury, S., et al. (2010) · PubMed

657. Effects of Imipramine, Scopolamine, Ketamine, NR2B and P2X7 Antagonists in a Chronic Model of Stress (CMS)-Induced Anhedonia

Balana, B., Papp, M., Lovenberg, T. W., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1066